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Aim: To determine the value of kidney revascularisation i patients with impaired renal function and correctable renal 
artery stenosis, the authors reviewed their surgical experience from 1978 to 1990. 
Patients and Methods: The study population included 23 patients with ischaemic nephropathy whose preoperative 
baseline creatinine level exceeded 20 mg/I (range 21-65 rag~l). This represents 20% of all patients operated on for renal 
artery disease during the same time interval. Preoperative risk profile, operative mortality, impact on hypertension and on 
renal function, and late survival were analysed. Renal function response to kidney revascularisation was defined as 
favourable (20% or more reduction of serum creatinine), moderate (stabilised serum creatinine values) or bad (further 
deterioration of renal function). All patients had atherosclerotic renal artery disease, involving asolitary kidney in five, both 
kidneys in 15 and one of the two kidneys in three patients. Hypertension was present in 74%. Revascularisation was 
unilateral in 10, bilateral in nine and associated with controlateral nephrectomy in four patients. 
Results: Four patients died postoperatively (three myocardial infarctions, one stroke). Four patients needed postoperative 
short-term dialysis. After operation, renal function improved in 13, stabilised in six and deteriorated in four patients (of 
whom two died). Follow-up among the survivors averaged 46 months. The mean serum creatinine value at last follow-up 
visit was 26.2 mg/l, a decrease of 7.7 mg/l compared to preoperative values (p < 0.05). Overall, 69% of azotemic patients 
submitted to renal revascularisation manifested a favourable response (45% improved and 24% stabilised). Three patients 
required long-term dialysis. The 5-year survival rate was 48%. 
Conclusion: These data suggest hat kidney revascularisation i  patients with ischaemic nephropathy can restore or 
stabilise renal function, preventing evolution and end-stage renal disease and dialysis dependency. 
Key Words: Renal insufficiency; Renal revascularisation; Renal artery surgery; Renovascular disease; Ischaemic 
nephropathy. 
Introduction 
Although the role of surgery for treating renovascular 
hypertension has been challenged by drug therapy 
improvement, the usefulness of kidney revascularisa- 
tion in preservation or recovery of renal function has 
been clearly stressed ever since the reports of Dean et 
al. 1 and Schreiber et al. 2 on the natural history of renal 
artery disease. Their observations emphasised the 
progressive nature of atherosclerotic renal artery 
disease, with subsequent loss of functional renal mass. 
Among 41 hypertensive patients with atherosclerotic 
renal artery disease, selected for medical treatment, 
Dean et al. ~ observed, progressive worsening of renal 
function (100% or more increase in serum creatinine, 
10% or more loss in renal length or 50% or more 
decrease in glomerular filtration rate) in 17 cases for 
whom operative management was ultimately war- 
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ranted. In four patients, a significant stenosis pro- 
gressed to total occlusion over a period of 28 months. 
Adequate pharmacological b ood pressure control 
could not obviate deterioration of renal function. In 
the study of Schreiber et al. 2 (non-surgical pproach of 
85 renovascular patients), 44% developed gradual 
progression of the stenosis and 16% of the lesions 
ultimately evolved towards total occlusion over a 
mean follow-up period of 52 months. Tollefson and 
Ernst 3 estimated the progressive narrowing of the 
diameter at about 5% per year in medically observed 
patients with renal artery stenosis. 
The sudden unexplained eterioration of renal 
function in an older vascular hypertensive patient 
should always raise suspicion of progression of renal 
artery disease to critical stenosis or thrombosis. 4-7 In 
selected azotemic patients, renal large vessel disease 
should be considered as a potentially treatable cause 
of renal failure and elective revascularisation as the 
most appropriate management. Mailloux et aI. 8 pre- 
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sumed a renal vascular cause in 16.5% of patients with 
end-stage renal disease, the third most frequent cause 
after glomerulonephritis and diabetes. In an angio- 
graphic survey of end-stage renal disease, Scoble et al. 9 
observed that 6% of the renal insufficiencies were 
caused by ischaemic nephropath3~ and that 14% of the 
patients on dialysis over the age of 50 years had 
ischaemic nephropathy. 
The present retrospective study was carried out to 
evaluate the potential role of renovascular repair in 
the management of patients whose renal artery dis- 
ease was associated with an impaired renal function. 
Severe renal dysfunction was considered if preopera- 
tive serum creatinine level exceeded 20 mg/1.1°-~3 
Criteria for blood pressure response and renal func- 
tion benefit are those described by Dean et al. 4 and 
Elmore et al. 1° 
Methods 
From 1978 to 1990, a total of 115 patients underwent 
renal artery surgery in our department. A subgroup of 
23 patients with chronically impaired renal function 
on admission (baseline serum creatinine level > 20 
rag/l) was identified. Renal revascularisations for 
acute renal ischaemia were not included. The pre- 
sumed cause of renal function impairment was ischae- 
mic nephropathy. In none of the patients was pre- 
existing primary renal parenchymal disease suspected 
(no urinary abnormalities, no systemic disease). Data 
analysed included age, sex, blood pressure, drug 
requirement, duration of hypertension, and selected 
risk factors that could influence the operative results 
(diabetes, ischaemic heart disease, stroke and aorto- 
iliacal disease). Preoperative evaluation included aor- 
torenal angiograph34 serum creatinine level, and iso- 
topic studies. Selection criteria for renal artery repair 
included preserved but delayed renal excretory func- 
tion and, in case of a malfunctioning kidney, a kidney 
length of at least 7 cm and residual perfusion on 
scintigraphy. Renin levels were not routinely meas- 
ured and were only available for seven patients. 
Operative data comprised the surgical procedure, type 
and extent of complications, need for haemodialysis 
and the cause of operative death (deaths occurring 
within 30 days after surgery). Patency of vascular 
reconstructions was controlled before hospital dis- 
charge by isotopic angioscintigraphy and when 
doubtful, documented by angiography. 
Special attention was given to the effect of renal 
revascularisation renal function and hypertension, 
as well as to the duration of the therapeutic effect. A 
favourable renal functional response to surgery was 
defined as a 20% or more reduction of serum crea- 
tinine level at first follow-up visit (2 months following 
surgery). A minimal benefit was considered if, at long 
term, renal excretory function had been stabilised, 
while failures included worsened postoperative r nal 
function as well as operative deaths. The renal 
function at last follow-up visit was compared with 
preoperative values. With regard to blood pressure 
response to surger3~ we discerned three categories of 
late outcome (at least 6 months after renal artery 
repair): cured, improved, and failed. Patients were 
defined as cured if normotensive (diastolic pressure 
less than 95 mmHg without medication) and as 
improved if diastolic pressure lowered at least 20 
mmHg with the same or reduced drug regimen. 
Treatment failures were patients with unchanged or 
worsened hypertension as well as operative deaths. 
The baseline values reported for blood pressure and 
serum creatinine represent averages of at least three 
separate determinations. 
Follow-up data (serum creatinine level, blood pres- 
sure, drug regimen, reoperation, and cause of death) 
were retrieved from medical records. Half of the 
patients were re-examined at the out-patient clinic 
during the last 6 months of 1992. For the remaining 
survivors, the most recent information, including 
blood pressure and serum creatinine, were obtained 
by correspondence with their family doctor. The 
prognostic value of factors likely to affect late survival 
was analysed. 
Statistics 
Means and S.D. were computed for continuous find- 
ings (e.g. age, serum creatinine levels, duration of 
hypertension) and frequencies for categorical data 
(e.g. sex, hypertension). Patient groups were com- 
pared by Mann-Whitney U-test, whereas for paired 
observations a Wilcoxon signed rank sum test was 
used. The Kaplan Meier method was used for deter- 
mining the late survival curve. Results were con- 
sidered to be significant at the 5% critical level 
(p < 0.05). 
Results 
Preoperative data 
Among the 23 patients with chronically impaired 
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renal function due to renovascular disease, there were 
16 men and seven women, aged 42-84 years (mean 
63 + 11 years). Two patients had diabetes type II but, 
as previously defined, without parenchymal glom- 
erular disease. The average serum creatinine level on 
admission was 34 + 12 rag/1 (extremes 21-65 mg/1). 
Based on serum creatinine values, the estimated 
glomerular filtration rate (EGFR) (Cockroft estima- 
tion 14) ranged from 15 to 50 ml/rnin (mean 30 + 9 ml/ 
rain). Among the 11 patients with severe renal 
dysfunction (creatinine >30 mg/1), one was on 
chronic haemodialysis. 
Seventeen patients (74%) of the study group also 
had drug resistant hypertension (diastolic pressure 
exceeding 95 mmHg despite optimised medical ther- 
apy). None of these patients were on ACE (angio- 
tensine converting enzyme) inhibitors, known to 
interfere with functional renal impairment. The mean 
duration of refractory hypertension was 41 months 
(range 6-96 months). The type of renal artery disease 
was always atherosclerotic, all patients having clinical 
evidence of advanced widespread atherosclerosis (e.g. 
ischaemic heart disease, carotid artery disease or 
aortoiliac disease). 
Angiographic data 
At angiograph~ only three patients had truly uni- 
lateral renal artery disease, with a non significant 
stenosis (< 70%) of the controlateral artery. In two 
cases, PTA (percutaneous angioplasty) was attempted, 
unsuccessfully, prior to surgery. Five patients with a 
previous nephrectomy had significant renal artery 
stenosis of their single kidney. Of the 15 patients with 
bilateral disease, seven had an occlusion of one of the 
renal arteries. On angiography an excretory par- 
enchymal renogram was not visualised in 10 non- 
functioning kidneys (including three solitary kidneys). 
Seven had a totally occluded renal artery and three a 
tight stenosis. Renal flow scan revealed residual 
perfusion in six of the 10 non-functioning kidneys. 
Surgical procedures 
The revascularisation was unilateral in 10 patients, 
bilateral in nine, and a controlateral nephrectomy of a 
renin producing shrunken kidney (< 7 cm in length) 
with a non-reconstructible artery concomitantly per- 
formed in four cases. Of the seven occluded renal 
arteries, three were repaired. In these cases, the kidney 
was at least 7 cm in length and there was evidence of 
residual glomerular filtration on renal perfusion scan. 
Distal renal artery patency had been maintained 
through a network of collateral vessels as assessed by 
intraoperative Doppler before arterial repair. 
Revascularisation was complete (no residual sten- 
osis left) in 21 patients (92%). In two patients, a 
controlateral stenosis of 70% was left uncorrected. A 
variety of operative techniques was used: aortorenal 
bypass in 10 cases (autogenous aphenous vein in 
eight and Dacron prosthesis in two cases), thromben- 
darterectomy in nine (ostial thrombendarterectomy in 
five patients, associated to patch angioplasty in three 
of them, and transaortic endarterectomy in four 
patients, always in association with aortic surgery), 
splenorenal nastomosis in two, hepatorenal bypass in 
one, and renal autotransplantation in one. The ade- 
quacy of renal artery repair was checked by intra- 
operative continuous wave Doppler. In doubtful 
cases, the surgeon opted for another strategy (two 
thrombendarterectomies and one splenorenal anasto- 
mosis were changed for venous aortorenal bypass). 
Concomitant aortoiliacal surgery was performed in 
nine patients. 
All nephrectomised kidneys were examined by the 
pathologist. Histology revealed nephrosclerotic 
changes in all shrunken kidneys, with hyalinisation of 
arterioles and patchy ischaemic fibrosis. There was no 
evidence of glomerulonephritis nor pyelonephritis. 
Postoperative outcome 
There were four operative deaths, yielding a mortality 
rate of 17%. The primary cause of death was cardiac in 
three cases and one had fatal stroke. 
Operative mortality was associated with long- 
standing hypertension or with severe renal dysfunc- 
tion (creatinine > 30 mg/1). Of the 17 hypertensive 
patients with impaired renal function, three died 
postoperatively. The latter had suffered hypertension 
for 66 months, on average, against 20 months for 14 
survivors. The main preoperative serum creatinine 
was 38 + 5 rag/1 for non-survivors and 33 + 13 mg/1 
for survivors (p = 0.09). The presence of coronary 
artery disease appeared to be a determinant for 
cardiac mortality, since all patients who died from 
myocardial infarction had a past history of ischaemic 
heart disease. Combined aortoiliac surgery (n = 9) led 
to a 22% mortality rate (2/9), against 14% for isolated 
renal revascularisation (NS). Operative morbidity 
included two non-fatal myocardial infarctions, three 
respiratory infections and one anastomotic leak neces- 
sitating reoperation. 
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Five patients required early postoperative haemo- 
dialysis, but only on temporary basis, except for the 
one patient who was already on chronic dialysis 
before surgery. One patient needed dialysis after 
primary failure of the arterial repair, and three were 
temporarily dialysed in spite of patent repair. None of 
the renal arterial reconstructions resulted in new 
dialysis dependency. In two patients, early thrombosis 
of the renal artery repair (one endarterectomy, one 
Dacron bypass graft) occurred (9% primary failure 
rate). One of them needed temporary dialysis. One 
had successful thrombectom~ while secondary 
nephrectomy was performed in the other patient 
whose controlateral repair was patent. 
After operation, serum creatinine dropped sig- 
nificantly to an average level of 30 + 17 mg/1 
(p = 0.05). It decreased by at least 20% in 13 patients 
(57%) and stabilised in six (26%), thus yielding an 
early beneficial effect of operation on renal function in 
83% of the patients. Almost all cases of deteriorating 
postoperative function (3/4) were observed in the 
group of patients with severe renal dysfunction 
(creatinine >30 mg/1). Two of them died post- 
operatively (one myocardial infarction, one stroke 
during dialysis). Of the two other operative deaths, 
the renal function was stabilised in one and improved 
in the other. Both suffered fatal myocardial infarction. 
Of the 19 patients who were discharged from hospital' 
12 (63%) left hospital with improved renal function, 
five (26%) with stabilised serum creatinine l vel while 
in two cases (11%), renal function further deteriorated 
(Table 1). The greatest improvements of renal function, 
a reduction of serum creatinine of 15 mg/1 or more 
(n = 5), were observed among patients with severe 
preoperative r nal functional impairment (creatinine 
>30 mg/1), although these patients were also at 
highest operative risk. Longstanding hypertension 
appeared to be a poor predictor of failure to benefit 
from operation: all four patients whose renal function 
worsened postoperatively had hypertension for a 
mean duration of 65 months vs. 22 months duration 
for the 13 hypertensive patients whose renal function 
improved or stabilised. 
Table 1. Operative outcome 
Creatinine Postoperative renal function Operative Total 
(rag/i) Unchanged Improved Deteriorated eaths 
20-30 4 7 1 1 13 
> 30 1 5 1 3 10 
5 12 2 4 23 
Long-term results 
Complete follow-up data were available for 17 of the 
19 patients discharged from hospital. Two patients 
were lost to follow-up at 6 and 18 months respectivel~ 
when they moved abroad. Follow-up periods ranged 
from 2 to 14 years (mean 46 + 31 months). At their last 
visit, 10 patients (59%) had improved serum creatinine 
levels, compared to their preoperative value, while a 
moderate benefit was noted in five patients whose 
preoperative creatinine l vel remained stable through- 
out the follow-up period. In two patients, renal 
excretory function worsened in spite of an initial 
technically successful revascularisation. They ulti- 
mately became dependent on haemodialysis, after 17 
and 36 months. In one of them a late thrombosis of an 
aortorenal bypass graft was documented 3 years later. 
Since no residual excretory function was evidenced by 
isotopic studies, no reoperation was considered. The 
other had angiographic evidence of graft patency 
despite progressive renal failure. The three patients 
requiring long-term dialysis died within the first year 
of dialysis. The average creatinine level at the last 
follow-up visit was 26 + 18 rag/l, thus yielding a 
significant decrease of 8 mg/1 from preoperative 
values (p < 0.05). The most restrictive valuation of the 
late operative result gave 43% (10/23) of the patients 
with improved renal function, 22% (5/23) with 
unchanged creatinine values, and 35% (8/23) failures, 
including all in-hospital deaths (n -- 4) and patients 
lost to follow up (n = 2). 
Regarding blood pressure control in long-term 
survivors who had preoperative hypertension 
(n = 14), 4 patients were cured (28%) after renal 
revascularisation, six were improved (43%), three 
remained unchanged (21%) and one worsened (7%). 
Severe preoperative renal dysfunction (serum crea- 
tinine >30 mg/1) was predictive for unfavourable 
response in terms of blood pressure control (p = 0.1). 
None of the survivors with preoperative hypertension 
and creatinine xceeding 30 mg/1 (n -- 4) was cured or 
improved. No other preoperative variable (e.g. dura- 
tion of hypertension) was significantly associated with 
the clinical response rate in terms of blood pressure 
control. 
During the follow-up period, six patients died. Four 
of these deaths (two patients on dialysis) were due to 
fatal myocardial infarction. One suffered a fatal stroke 
while on dialysis and another died of cancer. For the 
17 patients followed since hospital discharge, the 
actuarial 3-year and 5-year survival rates were 75% 
and 48% respectively. This is lower than the life 
expectation of an age- and sex-matched general 
Belgian population (83.6%, 5-year survival) 15 (Fig. 1). 
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Fig. 1. Survival estimates of 17 patients followed after operation for renal dysfunction (followed for 2 to 14 years), compared to life 
expectation f an age- and sex-matched Belgian population. (--) patients followed after operation for renal impairment (n= 17); (---) 
age- and sexqnatched Belgian population. 
Discuss ion  
Ischaemic nephropathy, defined as the combined 
presence of extraparenchymal occlusive renal artery 
disease and renal dysfunction ~ (arbitrarily defined as 
serum creatinine level exceeding 20 mg/11~13), has 
become an important indication for renovascular 
repair. It represents 10-30% of the large series of renal 
artery surgery. 4'1L12'16 Dean et al. 4 noted that this type 
of renal insufficiency is characterised by a more rapid 
decline of creatinine clearance, compared to other 
causes of renal insufficiency (4 ml /min /month  vs. 0.5 
ml /min/month) .  
Patients with renovascular disease and deteriorat- 
ing renal function are extremely ill patients with 
severe systemic atherosclerosis. They have a poor 
prognosis due to refractory hypertension, congestive 
heart failure and evolving renal insufficiency. The 
inherent high operative risk of renal revascularisation 
in these elderly polyvascular patients should be 
balanced against he potential benefits. The only way 
to answer this question would be a randomised 
clinical trial of surgical vs. medical management of
such patients. Up to now, such a study is not 
available. 
Since the Cooperative Study of Renovascular 
Hypertension (1975), ~7 it is well known that operative 
mortality after renal revascularisation is greatly influ- 
enced by preoperative r nal function impairment. The 
mortality rate reached 11.5% for patienLs with serum 
creatinine levels greater than 15 mg/1, vs. 4.7% for 
patients with normal renal function. This significant 
procedure related mortality tempered the enthusiasm 
for a surgical approach to renal failure, and percuta- 
neous balloon angioplasty (PTA) gained favourJ s-2° 
We consider percutaneous dilatation as a safe method 
for correction of short truncal renal artery stenosis. 
Nevertheless, many atherosclerotic renal artery lesions 
are not suitable for angioplasty, such as calcified ostial 
lesions, extensive total occlusions of the main artery 
and associated aortic occlusive or aneurysmal disease, 
characterised by an inherent risk of cholesterol embol- 
isation. 2° Weibull et al., 19 however, did not find any 
difference between the two methods (PTA versus 
surgery) for selected cases of unilateral ostial renal 
artery stenosis, with regard to blood pressure response 
or influence on renal function. Pattison et at. 2° also 
obtained excellent results with PTA in patients with 
renal failure (improvement in 40%, deterioration i  
10%). 
In recent series, mortality rates of 2-7% are men- 
tioned, contrasting with the high mortality in our 
series 1°-13 (Table 2). The leading cause of operative 
death was cardiac. A more adequate preoperative 
screening for ischaemic heart disease and eventual 
myocardial revascularisation prior to renal artery 
surgery might have reduced our operative mortality 
12 21 rate. ' Important factors that predispose to oper- 
ative death are prior history of ischaemic heart 
disease, 1~'12 and severe renal impairment (creatinine 
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Table 2. Results of renal revascularisation for renal dysfunction 
Reference Year n Mean creatinine % Mortal ity Late  Follow- 5 year 
Preoperatively Postoperatively Improvement-t dialysis up survival 
(mg/1) (mg/1) (early results) (%) (%) (months) (%) 
j49 3.3 26.0 32 -- Elmore t al. 10 1974-86 30§ 35 24 70 "~36 
Hallet et al. 11 1970-81 98~ 30 20 69 J 20 7.1 4.4 42 64% "~49 
Hansen et al. 12 1987-91 70~: *(15 ml~min) *(31 ml-~rnin) 85 5.7 4.2 24 40% 
Chaikof et al. 13 1982-92 50§ 31 -- 96/-42 2.0 18.4 49 62% 
*(25 mI/min) *(30 ml/min) "~" 54 
j57 17.0 13.0 46 48% Van Damme tal. 1978-90 235 33.9 26 83 -~26 
(this series) *(30 ml/min) 
* EGFR = estimated glomerular filtration rate. 
t the percentage of favourable r sponse is subdivided in% that had improved renal function (above) and in % whose renal function stabilised 
(below). 
:~ _- 20 mg/ml. 
§ _- 18 rng/ml. 
> 30 rag/l), n-13'22 Severe renal functional impairment 
(creatinine > 30 rag/l) is the most important predictor 
of operative death in our series, as well as in 
others, n-~3'22 In the large series (n = 98) at the Mayo 
Clinic, n the operative mortality was 3% for patients 
with initial creatinine of 20-29 rag/l, but reached 13% 
for patients with preoperative creatinine values above 
30 rag/1. This reflects more severe atherosclerosis at
renal and extrarenal levels. One may conclude that 
successful outcome of renal artery repair is more likely 
in patients with moderate deterioration of renal 
function, and that postponing the operation only 
makes it more hazardous. 13 We also found a sig- 
nificant relationship between longstanding (5-years or 
more) hypertension and operative mortality. One can 
explain the increased operative risk by more advanced 
atherosclerosis and cardiac failure as a result of 
longstanding hypertension. 
The beneficial effect of renal revascularisation is 
illustrated in our series by a positive postoperative 
response rate (improved or stabilised creatinine level) 
in 83% of patients and in 65% of the surviving patients 
at their last follow-up visit. Considering the 10 
patients who were candidates for chronic haemodial- 
ysis (preoperative s rum creatinine > 30 rag/l, exclud- 
ing the one patient who was on chronic dialysis), five 
could be definitely kept off of dialysis during the 
follow-up period of 46 months, three died perioper- 
atively, and two became dependent on dialysis in spite 
of successful revascularisation. Longstanding hyper- 
tension (duration of 5 years or more) decreased the 
chance of renal functional improvement after success- 
ful revascularisation. This could mean that certain 
patients had already hypertensive kidney damage 
(intrarenal small vessel disease). Such nephrangio- 
sclerotic changes will not be reversed by renal artery 
repair. Conversel~ patients with accelerated recent 
onset of hypertension and renal function decline 
have a greater chance to improve after renal 
revascularisation. 
Seventy-one percent of the survivors who were 
initially also hypertensive became normotensive (28 %) 
or had improved blood pressure control (43%) during 
4 16 11 23 follow-up. Dean et  al. ' and Hallett et aI. " obtained 
an improved blood pressure control in about 60% of 
their azotemic patients (creatinine >20 rag/l) sub- 
mitted to renal revascularisation. Hansen et al. 12 even 
mentioned an 80% success. This improvement seems 
to be durable. As in our series, the same author ~2 
observed less favourable clinical response to surgical 
correction in patients with longstanding hypertension. 
In addition, we found that severe preoperative renal 
dysfunction was predictive for poor blood pressure 
control. Chaikof et  al. 13 noted the same finding. One 
could speculate that some nephrangiosclerotic kid- 
neys were inappropriately revascularised. This 
assumption could not be verified because renal biop- 
sies were not available. Our selection criteria for 
kidney salvage are preoperative kidney size of at least 
7 cm length, residual isotopic glomerular filtration 
and disease free distal renal artery. Some authors 6'22-25 
insist on the value of renal biopsy in evaluating the 
viability of nephron units in a poorly functioning 
kidney and in prediction of functional recovery. If less 
than 50% of the glomeruli are involved by nephro- 
sclerosis, the kidney is considered salvageable. How- 
ever biopsy can be misleading and its usefulness is 
controversial. 1°,26 
We also argue for early intervention (serum crea- 
finine below 30 mg/1) to lower the operative risk and 
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.to assure a favourable functional response after renal 
~-;'evascularisation. I  Chaikof et al.'s series, 13 the 
incidence of late kidney failure and ultimate dialysis 
(despite initially successful renal revascularisation) 
was directly correlated to the preoperative azotemia: 
up to 32% of patients with preoperative chronic severe 
renal insufficiency (creatinine > 30 mg/1) came to 
dialysis within 3 years of renal revascularisation. The 
moderate arly improvement in these patients was not 
sustained at long follow-up. Jamieson et al., 22 Dean et 
at. 4 and Mercier et al. 26 also conclude that patients with 
end-stage renal failure are unlikely to benefit from 
surgerN because of the irreversible kidney damage 
(nephrangiosclerosis, glomerular scarring). Once a 
renovascular patient is on chronic dialysis, renal artery 
surgery can only exceptionally reverse dialysis needs. 
This finding is not shared by others. The Cleveland 
group 27 report nine cases of end stage renal failure 
caused by atherosclerotic renal artery occlusion, who 
benefited from renal revascularisation a d no longer 
remained ependent on dialysis. The kidney size was 
always more than 10 cm in length. This represents 1% 
of all dialysed patients in their centre. Hansen et at. 1~ 
reported that out of a total of 23 patients with extreme 
(creatinine > 30 rag/l) renal insufficiency 8/11 
patients dependent on chronic dialysis were improved 
by bilateral revascularisation. Pattison et al. 2° was able 
to wean 10 of 13 patients off chronic dialysis by 
percutaneous angioplasty. The duration of the pre- 
operative chronic dialysis was not mentioned in any of 
these reports. 
It is often stated that severe bilateral disease or 
ischaemia of a solitary kidney are necessary to cause 
functional renal impairment. 7'2~ In rare cases, uni- 
lateral tight stenosis can produce hypertension, severe 
enough to destroy the non-ischaemic ontrolateral 
kidney by nephrosclerosis. Unilateral renal artery 
repair can retrieve renal function in such cases. 4
Nevertheless, most authors 4'5'12"16 observed a better 
beneficial renal function response in patients who had 
their bilateral renal artery lesions or single kidney 
revascularised, compared to the renal function 
response in patients where only one of the two 
kidneys had a lesion needing correction. Dean et al. 16 
found a significant difference between unilaterally 
and bilaterally revascularised severely azotemic 
patients (creatinine > 30). In the latter, the mean 
serum creatinine dropped from 51 to 28 mg/1 ,  while it 
remained unchanged at 43 mg/1 in the former group. 
In our study, as well as in the recent series of Chaikof 
et ~ al., 13 there was no evidence of such relationship 
between the anatomic extent of the renal artery 
• ciisease and the result of its repair: bilateral repair did 
not reveal a propensity for greater success than 
unilateral kidney revascularisation. 
Late survival was largely affected by associated 
cardiovascular disease. 4'11-13'26 Failure to improve 
severe renal dysfunction also predisposes to early 4 
death during follow-up. In the series of Dean et al., ' 
44% (4/9) of the follow-up deaths were patients on 
chronic dialysis. In our series, half of the late deaths 
were patients on dialysis and myocardial infarction 
was the main cause. The 5-years survival is 50-60% 
and is superior to that obtained by medical manage- 
ment of similar patients with ischaemic nephropathy, 
as suggested in the non-randomised study of Novick 
et al. The estimations of MaiUoux et al. 8 are even 
more convincing: azotemic patients, almost 60 years 
and older, with uncorrected renal artery stenosis who 
progressed to dialysis, had a 5-years life expectation of
12%. In a large review on the outcome of dialysed 
patients, Held et al. 28 calculated an annual death rate 
of 34% for dialysed patients aged 65 years or olden 
The bad prognosis of terminal renal insufficiency in 
elderly atherosclerotic patients makes revascularisa- 
tion worthwhile to avoid dialysis. A more aggressive 
approach to the diagnosis and adequate treatment of 
associated ischaemic heart disease, not only allows 
operative risk to be reduced but also increases life 
expectancy. 11,3° 
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